The global market for digital wound measurement devices is likely to reach US$ 2,266.6 million in 2023. The market is expected to be worth US$ 3,293.3 million by 2033, expanding at 3.8% CAGR over the forecast period.
Digital wound measurement devices currently account for more than 10.9% share of the global wound care devices market. The market for digital wound measurement devices is expected to develop as the population ages and the incidence of diabetes, obesity, and chronic illnesses rise as a result of changes in people's lifestyles.
| Attribute | Details |
|---|---|
| Digital Wound Measurement Devices Market Size (2023) | US$ 2,266.6 million |
| Revenue Forecast (2033) | US$ 3,293.3 million |
| Global Market Growth Rate (2023 to 2033) | 3.8% CAGR |
| Dominant Wound Type | Diabetic Ulcers |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Technological breakthroughs have become increasingly important as the century progresses. The search for innovative wound care solutions is speeding up among healthcare providers. To address wound healing concerns, a variety of methodologies have been developed, ranging from cell proliferation assays, cell cytotoxicity assays, and cell viability assays to animal-based wound healing models.
According to frontiers.org, in chronic wounds, macrophages are critical for the persistence of the initial inflammatory response. As a result, immunomodulation is used to treat chronic wounds. Both intrinsic changes of HSPCs and an imbalanced wound microenvironment produce a sustained increase in the wound macrophages and inhibition of phenotypic switching, implying that the management of chronic wounds involves consideration of numerous factors.
High-throughput approaches are useful tools for delving further into pathophysiology and discovering new targets. However, their results must be confirmed.
The effectiveness of nanocrystalline dressings on chronic wounds is being investigated. Dressings made of silver are becoming increasingly popular. The effectiveness of silver-based nanocrystalline dressings has been proven in several in-vitro and animal experiments.
Porcine tests revealed that injuries treated with nanocrystalline silver dressings were extremely successful in promoting rapid wound healing, particularly in the days following an injury. Reduced levels of matrix metalloproteinase, a potential inflammatory stimulant, changed the proteolytic wound environment.
Human patients in randomized control trials have verified the usefulness of silver in wound healing. A group of six patients who were given ActicoatTM experienced healing and recovered after 194 days, while another 5-week-old ulcer patient-reported healing after 27 days.
Principal Consultant
Wounds are not considered diseases, even though their fatality rate is high than that of any chronic sickness. As a result, unlike cancer and other life-threatening illnesses like cardiovascular disease, wound care centers of excellence are hugely scattered.
The lack of a centralized framework to orchestrate and promote a multidisciplinary networking approach involving scientists, surgeons, health economists, social workers, specialty nursing, and internal medicine is decelerating the adoption of digital wound measurement devices in commercial healthcare locations.
| Particulars | Details |
|---|---|
| H1, 2021 | 4.75% |
| H1, 2022 Projected | 4.92% |
| H1, 2022 Outlook | 4.82% |
| BPS Change - H1, 2022 (O) - H1, 2022 (P) | (-) 10 ↓ |
| BPS Change - H1, 2022 (O) - H1, 2021 | (+) 07 ↑ |
The market for digital wound measurement devices is subject to data security policies, regulations pertaining to medical devices, and licensing requirements, as per the macroeconomic and industry factors.
The market observes a decline in the BPS values owed to the data discrepancies about the wound image projected by the user, as well as the limitations of the device in proving data related to the development of wound exudation or other indications. This limits the diagnostic capability of the device, thus translating into a reduced adoption rate.
With the advent of remote monitoring of disease conditions and telemedicine, however, the market is set to project a positive growth outlook through the projected years. The key developments within the market include the deployment of machine learning and AI for the identification of wound types and related indications.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The digital wound measurement devices market expanded at a CAGR of 5% from 2018 to 2022 and is expected to amass a revenue worth US$ 2,266.6 million by 2023 end.
In the medical world, wound treatment is an essential aspect. Wounds usually heal on their own or with the help of surgery. Certain wounds, particularly chronic wounds caused by prevalent morbidities such as diabetes mellitus, take a long time to heal or are unable to heal at all. Patients in such situations require sophisticated and advanced wound care from hospitals and other healthcare institutions.
Wound measuring is primarily done with the use of digital wound measurement tools. The gadgets are used to measure a wound three-dimensionally due to the integration of electronic medical record (EMR) software.
Digital wound measurement systems with 3D capabilities measure wound dimensions (area, length, width, and depth) and display them on a screen. These gadgets are used to convert line tracing into actual area measurements and calculate wound area change over time.
Clinicians can use the wound imaging device to rapidly, safely, and simply visualize microorganisms and measure wounds at the point of care, giving them the most information for precise treatment selection and fast healing. Private clinics are the most common users of wound imaging devices.
Digital wound care systems are very helpful in the healthcare world. Furthermore, the advantages of digital wound measurement techniques and a rise in awareness about the need to cut healthcare expenses are propelling the market forward.
Digital wound measurement device demand is predicted to progress at a CAGR of 3.8% from 2023 to 2033, with the global market expected to close in on a valuation of US$ 3,293.3 million by 2033.
| Duration | Market Analysis |
|---|---|
| Short-term Growth | The market is anticipated to reach US$ 2,442.13 million by 2025. The market is projected to witness the launch of new wound measurement apps, equipped with recent technology, thereby pushing the market forward. One such recent app is Swift App, which measures, photographs, and records wound data without having to touch the wound. Widespread use of improved digital wound measurement tools, as well as the advent of telehealth for wound care, are driving the rise and need for the digital wound measurement devices market. |
| Medium-term Growth | By 2028, the market is estimated to generate revenue of US$ 2,731.25 million. The market is assessed to observe heightened adoption of sophisticated digital tools. Additionally, the advent of telehealth is also projected to transform the wound care industry. Furthermore, the growth of the handheld wound imaging & measurement devices market is projected to coincide with the growth of the digital wound measurement devices market over the forecast period. |
| Long-term Growth | By the end of 2033, the market is expected to amass a total of US$ 3,293.3 million. The rise in chronic health conditions is projected to have a significant influence on the market in the coming 10 years. Surging clinicians, dependent on technological advancements, to keep track of the treatment’s progress, are also expected to boost market development over the upcoming years. |
These market findings for digital wound measurement devices cover North America, Latin America, Europe, East Asia, South Asia & Pacific, and the Middle East and Africa.
The market for digital wound measurement devices in North America is being propelled by rapid technological improvements due to the increased frequency of chronic illnesses. Diabetic foot ulcers are becoming more common as the prevalence of diabetes mellitus among people rises.
Europe is expected to be the second most prominent region, owing to increased public funding for improved wound care management research. Because of raising awareness of the therapy for chronic wounds and the increasing demand for these treatments, the Europe market is predicted to develop at a strong CAGR.
Asia Pacific market is predicted to rise steadily because of rising per capita healthcare spending. Furthermore, market participants in this region are making significant expenditures, which is expected to boost demand for digital wound measurement equipment. Latin America and the Middle East & Africa may account for a small market share, because of their underpenetrated market.
| The United States Market Size (2023) | Estimated CAGR (2023 to 2033) |
|---|---|
| US$ 1,026 million | 3.3% |
| China Market Size (2023) | Estimated CAGR (2023 to 2033) |
|---|---|
| US$ 130.9 million | 4.2% |
| Canada Market Size (2023) | Estimated CAGR (2023 to 2033) |
|---|---|
| US$ 444.7 million | 4.4% |
| Germany Market Size (2023) | Estimated CAGR (2023 to 2033) |
|---|---|
| US$ 210.5 million | 3.5% |
| The United Kingdom Market Size (2023) | Estimated CAGR (2023 to 2033) |
|---|---|
| US$ 163.7 million | 5.6% |
The United States is developing as a lucrative pocket in the North America digital wound measurement devices market, with sales of digital wound measurement devices projected to remain high over the forecast period.
Increased healthcare investments, the existence of prominent market companies, and the rise in diabetic patients are all contributing to the industry's growth. Additionally, the rapid use of technologically advanced medical equipment in hospitals, clinics, and home care settings is also propelling market development.
Over the projected period, attractive healthcare reimbursement policies in the United States are likely to be the primary driver of the market.
| Historical CAGR (2017 to 2022) | 5.2% |
|---|---|
| Forecast CAGR (2023 to 2033) | 3.3% |
Every year, nearly 10 lakh people in India are moderately or seriously burned, according to the WHO. The increasing rate of annual burn incidents in India is driving wound care product sales. India has a lot of opportunities for growth in the medical field. Hence in India's digital wound measurement devices market, producers have a lot of room to expand.
By 2025, the Indian government intends to expand public health spending to 2.5% of the country's GDP. Also, the increasing geriatric and diabetic population along with rising healthcare infrastructure are bolstering the market growth.
Germany digital wound measurement devices industry is projected to attain US$ 210.5 million by 2033. Over the forecast period, the market is expected to register a 3.5% CAGR. Regional growth can be attributed to the approval of technologically progressive devices in the course of the next 10 years. Additionally, the surging cases of diabetes and chronic wounds are also pushing the market forward.
The market is also witnessing the growth of 3D-enabled digital wound measurement devices to measure wound dimensions and assist in recording wound recovery. As a result, even the regional 3D digital wound measurement devices market is projected to thrive over the forecast period.
| Historical CAGR (2017 to 2022) | 4.1% |
|---|---|
| Forecast CAGR (2023 to 2033) | 3.5% |
| Taxonomy | Wound Type |
|---|---|
| Top Segment | Diabetic Ulcer |
| Forecast CAGR | 3.6% |
| Taxonomy | End User |
|---|---|
| Top Segment | Hospitals |
| Forecast CAGR | 3.7% |
| Historical CAGR of Diabetic Ulcer | 5.2% |
|---|---|
| Forecast CAGR of Diabetic Ulcer | 3.6% |
The rising prevalence of diabetic ulcers has heightened the demand for more effective wound treatment techniques. Diabetic foot ulcers affect 9.1 million to 26.1 million people worldwide each year, according to the National Center for Biotechnology Information. Diabetic ulcers are expected to account for more than 43.9% of the market share in the global landscape in 2022.
Chronic wounds are difficult-to-heal conditions that can be identified by symptoms such as loss of skin or tissue around the incision or the length of time it takes to heal. When a wound becomes chronic, it requires rigorous medical intervention and wound care products to be treated. Chronic wounds are estimated to cross 20.7% of the global market share in 2023.
Growing demand for traumatic wounds, such as abrasions, lacerations, skin wounds, bites, burning, and penetrating trauma wounds, is projected to aid in segment growth. Further, the growth in road accidents increasing the incidence rate of traumatic wounds. In 2023, traumatic wounds are predicted to account for more than 12.9% of the global market share.
| Historical CAGR (2017 to 2022) | 4.8% |
|---|---|
| Forecast CAGR (2023 to 2033) | 3.7% |
The hospital segment is a prominent end user of digital wound measurement devices. The segment is projected to witness a CAGR of 3.7% over the forecast period. The increase in hospital visits for external injuries is projected to boost the adoption of digital wound measurement devices in hospitals. Additionally, the surging patient pool requiring wound care treatment is expected to positively influence the adoption of chronic wound devices among healthcare providers.
Key manufacturers of digital wound measurement devices are Perceptive Solutions Inc., ARANZ Medical, Smith & Nephew plc., WoundVision Inc., WoundMatrix Inc., KCI, Parable Health, Hitachi Healthcare Americas, 3M Company, and WoundRight Technologies.
Market shares of the aforementioned players are increasing due to new product launches, strengthening of research and development capabilities, and collaborations and partnerships.
To maintain their market position, manufacturers are concentrating on inventing innovative wound measurement tools. These items can better treat wounds, prevent bacterial infections, and speed up the healing process. Key developments in the market are as follows
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2018 to 2022 |
| Market Analysis | US$ million for Value, Units for Volume |
| Key Regions Covered |
|
| Key Countries Covered |
|
| Key Market Segments Covered |
|
| Key Companies Profiled |
|
| Pricing | Available upon Request |
The global sales of such devices are poised to surge at 3.8% CAGR through 2033.
The market is valued at US$ 2,266.6 million in 2023.
Rising diabetes mellitus cases are expected to drive North America market through 2033.
The market is expected to record a CAGR of 3.5% through 2033.
1. Executive Summary | Digital Wound Measurement Devices Market
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Product, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product, 2023 to 2033
5.3.1. Contact Wound Measuring Devices
5.3.2. Non-contact Wound Measuring Devices
5.4. Y-o-Y Growth Trend Analysis By Product, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Product, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Wound Type
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By Wound Type, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Wound Type, 2023 to 2033
6.3.1. Diabetic Ulcers
6.3.2. Chronic Wounds
6.3.3. Burns
6.3.4. Incisional
6.3.5. Traumatic
6.4. Y-o-Y Growth Trend Analysis By Wound Type, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By Wound Type, 2023 to 2033
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) Analysis By End User , 2018 to 2022
7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User , 2023 to 2033
7.3.1. Hospitals
7.3.2. Clinics
7.3.3. Community Centres
7.4. Y-o-Y Growth Trend Analysis By End User , 2018 to 2022
7.5. Absolute $ Opportunity Analysis By End User , 2023 to 2033
8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022
8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. South Asia
8.3.5. East Asia
8.3.6. Oceania
8.3.7. MEA
8.4. Market Attractiveness Analysis By Region
9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. USA
9.2.1.2. Canada
9.2.2. By Product
9.2.3. By Wound Type
9.2.4. By End User
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Product
9.3.3. By Wound Type
9.3.4. By End User
9.4. Key Takeaways
10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Rest of Latin America
10.2.2. By Product
10.2.3. By Wound Type
10.2.4. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product
10.3.3. By Wound Type
10.3.4. By End User
10.4. Key Takeaways
11. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. U.K.
11.2.1.3. France
11.2.1.4. Spain
11.2.1.5. Italy
11.2.1.6. Rest of Europe
11.2.2. By Product
11.2.3. By Wound Type
11.2.4. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product
11.3.3. By Wound Type
11.3.4. By End User
11.4. Key Takeaways
12. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. India
12.2.1.2. Malaysia
12.2.1.3. Singapore
12.2.1.4. Thailand
12.2.1.5. Rest of South Asia
12.2.2. By Product
12.2.3. By Wound Type
12.2.4. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product
12.3.3. By Wound Type
12.3.4. By End User
12.4. Key Takeaways
13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. China
13.2.1.2. Japan
13.2.1.3. South Korea
13.2.2. By Product
13.2.3. By Wound Type
13.2.4. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product
13.3.3. By Wound Type
13.3.4. By End User
13.4. Key Takeaways
14. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Country
14.2.1.1. Australia
14.2.1.2. New Zealand
14.2.2. By Product
14.2.3. By Wound Type
14.2.4. By End User
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Product
14.3.3. By Wound Type
14.3.4. By End User
14.4. Key Takeaways
15. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
15.2.1. By Country
15.2.1.1. GCC Countries
15.2.1.2. South Africa
15.2.1.3. Israel
15.2.1.4. Rest of MEA
15.2.2. By Product
15.2.3. By Wound Type
15.2.4. By End User
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Product
15.3.3. By Wound Type
15.3.4. By End User
15.4. Key Takeaways
16. Key Countries Market Analysis
16.1. USA
16.1.1. Pricing Analysis
16.1.2. Market Share Analysis, 2022
16.1.2.1. By Product
16.1.2.2. By Wound Type
16.1.2.3. By End User
16.2. Canada
16.2.1. Pricing Analysis
16.2.2. Market Share Analysis, 2022
16.2.2.1. By Product
16.2.2.2. By Wound Type
16.2.2.3. By End User
16.3. Brazil
16.3.1. Pricing Analysis
16.3.2. Market Share Analysis, 2022
16.3.2.1. By Product
16.3.2.2. By Wound Type
16.3.2.3. By End User
16.4. Mexico
16.4.1. Pricing Analysis
16.4.2. Market Share Analysis, 2022
16.4.2.1. By Product
16.4.2.2. By Wound Type
16.4.2.3. By End User
16.5. Germany
16.5.1. Pricing Analysis
16.5.2. Market Share Analysis, 2022
16.5.2.1. By Product
16.5.2.2. By Wound Type
16.5.2.3. By End User
16.6. United kingdom
16.6.1. Pricing Analysis
16.6.2. Market Share Analysis, 2022
16.6.2.1. By Product
16.6.2.2. By Wound Type
16.6.2.3. By End User
16.7. France
16.7.1. Pricing Analysis
16.7.2. Market Share Analysis, 2022
16.7.2.1. By Product
16.7.2.2. By Wound Type
16.7.2.3. By End User
16.8. Spain
16.8.1. Pricing Analysis
16.8.2. Market Share Analysis, 2022
16.8.2.1. By Product
16.8.2.2. By Wound Type
16.8.2.3. By End User
16.9. Italy
16.9.1. Pricing Analysis
16.9.2. Market Share Analysis, 2022
16.9.2.1. By Product
16.9.2.2. By Wound Type
16.9.2.3. By End User
16.10. India
16.10.1. Pricing Analysis
16.10.2. Market Share Analysis, 2022
16.10.2.1. By Product
16.10.2.2. By Wound Type
16.10.2.3. By End User
16.11. Malaysia
16.11.1. Pricing Analysis
16.11.2. Market Share Analysis, 2022
16.11.2.1. By Product
16.11.2.2. By Wound Type
16.11.2.3. By End User
16.12. Singapore
16.12.1. Pricing Analysis
16.12.2. Market Share Analysis, 2022
16.12.2.1. By Product
16.12.2.2. By Wound Type
16.12.2.3. By End User
16.13. Thailand
16.13.1. Pricing Analysis
16.13.2. Market Share Analysis, 2022
16.13.2.1. By Product
16.13.2.2. By Wound Type
16.13.2.3. By End User
16.14. China
16.14.1. Pricing Analysis
16.14.2. Market Share Analysis, 2022
16.14.2.1. By Product
16.14.2.2. By Wound Type
16.14.2.3. By End User
16.15. Japan
16.15.1. Pricing Analysis
16.15.2. Market Share Analysis, 2022
16.15.2.1. By Product
16.15.2.2. By Wound Type
16.15.2.3. By End User
16.16. South Korea
16.16.1. Pricing Analysis
16.16.2. Market Share Analysis, 2022
16.16.2.1. By Product
16.16.2.2. By Wound Type
16.16.2.3. By End User
16.17. Australia
16.17.1. Pricing Analysis
16.17.2. Market Share Analysis, 2022
16.17.2.1. By Product
16.17.2.2. By Wound Type
16.17.2.3. By End User
16.18. New Zealand
16.18.1. Pricing Analysis
16.18.2. Market Share Analysis, 2022
16.18.2.1. By Product
16.18.2.2. By Wound Type
16.18.2.3. By End User
16.19. GCC Countries
16.19.1. Pricing Analysis
16.19.2. Market Share Analysis, 2022
16.19.2.1. By Product
16.19.2.2. By Wound Type
16.19.2.3. By End User
16.20. South Africa
16.20.1. Pricing Analysis
16.20.2. Market Share Analysis, 2022
16.20.2.1. By Product
16.20.2.2. By Wound Type
16.20.2.3. By End User
16.21. Israel
16.21.1. Pricing Analysis
16.21.2. Market Share Analysis, 2022
16.21.2.1. By Product
16.21.2.2. By Wound Type
16.21.2.3. By End User
17. Market Structure Analysis
17.1. Competition Dashboard
17.2. Competition Benchmarking
17.3. Market Share Analysis of Top Players
17.3.1. By Regional
17.3.2. By Product
17.3.3. By Wound Type
17.3.4. By End User
18. Competition Analysis
18.1. Competition Deep Dive
18.1.1. Perceptive Solutions Inc.
18.1.1.1. Overview
18.1.1.2. Product Portfolio
18.1.1.3. Profitability by Market Segments
18.1.1.4. Sales Footprint
18.1.1.5. Strategy Overview
18.1.1.5.1. Marketing Strategy
18.1.2. ARANZ Medical
18.1.2.1. Overview
18.1.2.2. Product Portfolio
18.1.2.3. Profitability by Market Segments
18.1.2.4. Sales Footprint
18.1.2.5. Strategy Overview
18.1.2.5.1. Marketing Strategy
18.1.3. Smith & Nephew plc.
18.1.3.1. Overview
18.1.3.2. Product Portfolio
18.1.3.3. Profitability by Market Segments
18.1.3.4. Sales Footprint
18.1.3.5. Strategy Overview
18.1.3.5.1. Marketing Strategy
18.1.4. WoundVision Inc.
18.1.4.1. Overview
18.1.4.2. Product Portfolio
18.1.4.3. Profitability by Market Segments
18.1.4.4. Sales Footprint
18.1.4.5. Strategy Overview
18.1.4.5.1. Marketing Strategy
18.1.5. WoundMatrix Inc.
18.1.5.1. Overview
18.1.5.2. Product Portfolio
18.1.5.3. Profitability by Market Segments
18.1.5.4. Sales Footprint
18.1.5.5. Strategy Overview
18.1.5.5.1. Marketing Strategy
18.1.6. Rubitection Inc.
18.1.6.1. Overview
18.1.6.2. Product Portfolio
18.1.6.3. Profitability by Market Segments
18.1.6.4. Sales Footprint
18.1.6.5. Strategy Overview
18.1.6.5.1. Marketing Strategy
18.1.7. Parable Health
18.1.7.1. Overview
18.1.7.2. Product Portfolio
18.1.7.3. Profitability by Market Segments
18.1.7.4. Sales Footprint
18.1.7.5. Strategy Overview
18.1.7.5.1. Marketing Strategy
18.1.8. Hitachi Healthcare Americas
18.1.8.1. Overview
18.1.8.2. Product Portfolio
18.1.8.3. Profitability by Market Segments
18.1.8.4. Sales Footprint
18.1.8.5. Strategy Overview
18.1.8.5.1. Marketing Strategy
18.1.9. 3M Company
18.1.9.1. Overview
18.1.9.2. Product Portfolio
18.1.9.3. Profitability by Market Segments
18.1.9.4. Sales Footprint
18.1.9.5. Strategy Overview
18.1.9.5.1. Marketing Strategy
18.1.10. WoundRight Technologies
18.1.10.1. Overview
18.1.10.2. Product Portfolio
18.1.10.3. Profitability by Market Segments
18.1.10.4. Sales Footprint
18.1.10.5. Strategy Overview
18.1.10.5.1. Marketing Strategy
19. Assumptions & Acronyms Used
20. Research Methodology
Explore Healthcare Insights
View Reports
Digital Wound Measurement Devices Market
